News

Online Testing Tool Identifies People Likely to Benefit from Genetic Testing for Inherited Risk for Certain Cancers

An online tool developed by researchers and physicians at Dana-Farber Cancer Institute can accurately and rapidly identify people who should undergo testing for inherited genetic changes that raise the risk of developing certain cancers, a new study shows.

News

Bispecific Antibodies Continue the Promise of Immunotherapy

Until recently, when adults with acute lymphocytic leukemia (ALL) weren't cured or put into prolonged remission by standard chemotherapy, "there really was no good treatment option," says Marlise Luskin, MD, MSCE, a leukemia specialist ...

News

Monica Bertagnolli Named New Director of National Cancer Institute

Today, President Joe Biden announced that he is appointing Monica Bertagnolli, MD, surgical oncologist in the Dana-Farber Brigham Cancer Center and at Brigham and Women’s Hospital and member of the Gastrointestinal and Sarcoma Treatment ...

News

New Breast Cancer Clinical Trials

In the Breast Oncology Program at Dana-Farber Brigham Cancer Center, we offer breast cancer patients access to more than 50 clinical trials at a time — many of which are changing the standard of care worldwide and are not available elsewhere. ...

News

2022 Master Class for Oncologists

Register here for the latest practices and guidelines in medical oncology. We look forward to bringing learners together again with expert faculty presentations and interactive panel discussions.

Document

Identification & Management of Lynch Syndrome in Clinical Practice

This conference will educate attendees on state-of-the-art approaches to managing individuals with known or suspected Lynch syndrome, a common, inherited form of cancer predisposition.